Cancer type Author % methylation.
Multiple Myeloma (26) Margaret et al. 67%
Paediatric AML (25) Ekmekd et al. 70%
Adult AML (25) Ekmekd et al. 55%
Childhood ALL (27) Gutierrez et al. 23.2%
B cell lymphoma (24) Sung Kim et al 60.9%
Ocular adnexal lymphoma (28) Ho-Kyung et al. 94.3%
Head and neck cancer (30) Masayuki et al. 23.8%
Myelodysplastic syndrome (29) J Qian et al. 62.7%
Hematological malignancies. (31) Tamer et al. 28%
CML (32) Eisuke et al. 6%
CML (33) J Qian et al. 51%
Our study   45.5%
Table 6: Review of DAPK1 methylation in different malignancies.